Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology
This study investigates the safety and adverse effects of intratumoral (IT) mistletoe injections in 123 cancer patients, examining the incidence and severity of adverse drug reactions (ADRs) from 862 injections using preparations like Abnoba Viscum and Helixor. The study found that 21.1% of patients experienced mild ADRs, including localized reactions
June 26, 2025
No Comments